Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Drug-Related Side Effects and Adverse Reactions × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Methylprednisolone 2 pegaspargase 1 Vincristine 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Methylprednisolone Hemisuccinate 1 Methotrexate 1 Mercaptopurine 1 Leucovorin 1 Infliximab 1 Hydrocortisone 1 Fecal Microbiota Transplantation 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexrazoxane 1 Dexamethasone 1 Cytarabine 1 Cyclophosphamide 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡